Compare BIO & KT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIO | KT |
|---|---|---|
| Founded | 1952 | 1981 |
| Country | United States | South Korea |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Telecommunications Equipment |
| Sector | Industrials | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2B | 8.6B |
| IPO Year | N/A | 1999 |
| Metric | BIO | KT |
|---|---|---|
| Price | $300.28 | $18.68 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $358.50 | N/A |
| AVG Volume (30 Days) | 170.4K | ★ 1.9M |
| Earning Date | 10-29-2025 | 02-10-2026 |
| Dividend Yield | N/A | ★ 3.54% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.80 |
| Revenue | $2,557,500,000.00 | ★ $19,913,724,353.00 |
| Revenue This Year | $1.77 | $7.66 |
| Revenue Next Year | $2.30 | N/A |
| P/E Ratio | ★ N/A | $12.81 |
| Revenue Growth | N/A | ★ 5.39 |
| 52 Week Low | $211.43 | $15.49 |
| 52 Week High | $373.69 | $21.61 |
| Indicator | BIO | KT |
|---|---|---|
| Relative Strength Index (RSI) | 39.06 | 51.70 |
| Support Level | $298.02 | $18.65 |
| Resistance Level | $307.78 | $19.10 |
| Average True Range (ATR) | 8.35 | 0.31 |
| MACD | -2.13 | 0.05 |
| Stochastic Oscillator | 16.30 | 39.15 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
KT is South Korea's largest fixed-line telecom operator, with around 11.5 million fixed-line broadband customers and 9.5 million IPTV customers, and is the second-largest wireless operator with 28 million subscribers. Additionally, it has a number of nontelecom businesses, including real estate, payment processing, artificial intelligence, and IDC/cloud services, many of which are the focus of its growth strategy. The company was formed from the previously government-owned, monopoly telecom business and was listed in 1998. After selling its mobile business in 1994 (forming its mobile competitor, SK Telecom) KT created its own mobile operator in 1997.